Skip to main content
. Author manuscript; available in PMC: 2013 Jan 9.
Published in final edited form as: Curr Cancer Drug Targets. 2011 May;11(4):451–464. doi: 10.2174/156800911795538066

Figure 3. STAT3 signaling.

Figure 3

Binding of IL-6 to the receptor triggers receptor heterodimerization with the gp130. Subsequently, JAKs are activated by phosphorylation which results in the recruitment of STAT3 to the receptor. Phosphorylated STAT3 dimerize and translocate to the nucleus, bind DNA and regulate the expression of its target genes.